Reducing burden while improving site selection and study forecasts

In recent years, the clinical development function has been adopting software tools to improve productivity and speed study timelines. Yet, there are still pockets of opportunity for manual tasks to be automated and for paperwork to be digitised.

As a case in point, one global pharmaceutical company recently began using an electronic system for identifying patients who may be eligible to participate in an extensive clinical program comprised of dozens of protocols. The system can be customised to identify and “reserve” prospective subjects for Phase III trials in any therapeutic area.